logo
ProjectArchived

Next Generation PrEP (R01)

Sector: Hospital • Location: United States of America

Source: Grants.gov

Purpose. The National Institute of Allergy and Infectious Diseases (NIAID) encourages applications from institutions/organizations to participate in this Funding Opportunity Announcement (FOA), Next Generation PrEP. The purpose of this FOA is to: Develop the basic and preclinical framework needed for development of second and subsequent generations of PrEP agents; Create a rational pipeline for

Status
Closed
Sector
Hospital, Power Transmission, Government, Education, Hotel, Power Generation (CCGT)
Location
United States of America
Updated
22 Jul 2026
Source
Grants.gov

ConstructChat

Ask ConstructChat about Next Generation PrEP (R01)

Pick a question to edit it, or write your own.

First answer free · no account

I am a

Project Information FAQ

Project Information

5 Q
The project “Next Generation PrEP (R01)” is an infrastructure initiative in the Hospital sector, located in United States of America. Taiyo aggregates data on it from Grants.gov.

Participants

Sponsoring Agency

Status

Original status

archived

Taiyo status

Closed

Taiyo last update

2026-07-22

Contact

Not available for this record.

Description

Description

Purpose. The National Institute of Allergy and Infectious Diseases (NIAID) encourages applications from institutions/organizations to participate in this Funding Opportunity Announcement (FOA), Next Generation PrEP. The purpose of this FOA is to: Develop the basic and preclinical framework needed for development of second and subsequent generations of PrEP agents; Create a rational pipeline for the discovery of New Molecular Entities (NMEs) and the identification of existing antiretrovirals (approved for HIV treatment, and those that are not approved but may have extensive clinical data) that can be used for the next generation of PrEP agents; Develop preclinical algorithms with clear go/no go criteria for identifying and prioritizing PrEP candidates for advancement to clinical evaluation; Generate PK/PD models to assess protective effects at mucosal sites of HIV transmission; and Conduct proof-of-concept safety and efficacy studies in animal models. Mechanism of Support. This FOA will utilize the NIH Research project (R01) grant mechanism. Funds Available and Anticipated Number of Awards. NIAID intends to commit approximately $1.8M in FY 2011 to fund 3-5 applications submitted in response to this FOA. Awards issued under this FOA are contingent upon the availability of funds and the submission of a sufficient number of meritorious applications

Budget

Location

Country

United States of America (USA)

Source

Source reliability

High

Source

Grants.gov

URL

More Details

Record type

Project

Sector

Hospital, Power Transmission, Government, Education, Hotel, Power Generation (CCGT)

Article published date

2023-06-01

More on this project

Research

Free account

View all details

You are reading the public part. A free account opens the rest:

  • Every detail on this project
  • News and media coverage
  • Technical research
View all details

Free account · no card · lands you back on this project